In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses



Drugs

How financial services firms manage AI applications

Counsel at Equifax, Morgan Stanley and American Express say streamlining relationships with external counsel and disclosing data sets correctly are key to prosecuting artificial intelligence patents. Read more... 

Pharma companies unconcerned by NHS notification in preliminary injunctions

In-house sources say changes to the England and Wales Patents Court Guide setting out that health authorities must be notified in the case of an injunction for an approved therapeutic product are not a cause for concern. Read more... 

Digital transformation pushes firms to embrace open source

Microsoft, JPMorgan and Wells Fargo explain how the cloud, AI and data sets technologies are driving them to open source and how that change is affecting patent strategies. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Leaders at IP boutique say the decision to pursue sponsorless partnership with the specialised investment arm of a private equity firm comes at a time of ‘profound transformation’ in the profession
Gift this article